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ABSTRACT
Purpose: Health-related quality of life (HRQoL) is 
considered a representative outcome in the evaluation 
of chronic disease management initiatives emphasizing 
patient-centered care. We evaluated the association 
between receipt of processes-of-care (PoC) for 
diabetes and HRQoL.
Methods: This cross-sectional study used self-
reported data from non-institutionalized adults with 
diabetes in a Swiss canton. Outcomes were the 
physical/mental composites of the short form health 
survey 12 (SF-12) physical composite score, mental 
composite score (PCS, MCS) and the Audit of 
Diabetes-Dependent Quality of Life (ADDQoL). Main 
exposure variables were receipt of six PoC for diabetes 
in the past 12 months, and the Patient Assessment of 
Chronic Illness Care (PACIC) score. We performed 
linear regressions to examine the association between 
PoC, PACIC and the three composites of HRQoL. 
Results: Mean age of the 519 patients was 64.5 years 
(SD 11.3); 60% were male, 87% reported type 2 or 
undetermined diabetes and 48% had diabetes for over 
10 years. Mean HRQoL scores were SF-12 PCS: 43.4 
(SD 10.5), SF-12 MCS: 47.0 (SD 11.2) and ADDQoL:
−1.6 (SD 1.6). In adjusted models including all six 
PoC simultaneously, receipt of influenza vaccine was 
associated with lower ADDQoL (β=−0.4, p≤0.01) and 
foot examination was negatively associated with SF-12 
PCS (β=−1.8, p≤0.05). There was no association or 
trend towards a negative association when these PoC 
were reported as combined measures. PACIC score 
was associated only with the SF-12 MCS (β=1.6,
p≤0.05).
Conclusions: PoC for diabetes did not show a 
consistent association with HRQoL in a cross-sectional 
analysis. This may represent an effect lag time between 
time of process received and health-related quality of 
life. Further research is needed to study this complex 
phenomenon.
BACKGROUND
The number of people living with diabetes 
mellitus (DM) continues to rise, with an esti-
mated 371 million individuals around the
world who were affected by the illness in 
2012.1 The consequences of diabetic illness, 
such as blindness and kidney disease, place a 
high toll on patients and the social system, not 
only in terms of functional life years lost, but 
also in terms of the morbidity that leads to 
disability and decreased quality of life.1–4
Given the signiﬁcant impact of diabetes on 
patient lives and the responsibility of disease 
self-management on the individual with dia-
betes, health-related quality of life (HRQoL) is 
acknowledged as an important outcome to 
consider when developing and assessing 
interventions targeting these patients.5
Furthermore, novel chronic disease manage-
ment initiatives emphasize a more ‘patient-
centered’ model,6 with increased attention to 
patient reported outcome measures (PROMs) 
such as HRQoL.7
However, although HRQoL is accepted as 
a diabetes-relevant outcome, having demon-
strated positive associations with patients’ 
daily life-functioning, disease management 
and prognosis,5 8 –10 efforts for assessing 
the quality of diabetes care have 
primarily focused on the development and 
monitoring of process measures and 
clinical outcomes. For almost two decades, 
system initiatives in the USA and across the 
globe have poured
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resources into the implementation of speciﬁc process 
measures11–13 that improve relevant intermediate and 
ultimate end points such as glycated hemoglobin 
(HbA1C), and diabetic complications, comorbidities and 
overall prognosis, respectively.12 14 15 However, it is not yet 
known how these process measures affect PROMs in 
patients with diabetes, such as HRQoL.
Since process indicators are accepted as measures of 
high-quality diabetes care,16 we ask whether these estab-
lished measures also ultimately translate into an 
improved patient-centered outcome. Therefore, the aim 
of this study was to examine whether receipt of highly 
utilized process(es)-of-care (PoC) measures was related 
to the HRQoL in patients with diabetes. We hypothe-
sised that there would be a positive association between 
patient’s receipt of PoC, as measured by individual and 
combined measures and HRQoL outcomes.
METHODS
Study design
We used data from a cross-sectional survey of patients 
with diabetes.
Setting, population and recruitment
In the fall of 2011 and summer of 2012, patients with 
diabetes were recruited by community-based pharmacies 
registered in the canton of Vaud, Switzerland, a large 
French-speaking canton (state) with over 720 000 inhabi-
tants.17 Patients were eligible if they came to the phar-
macy with a prescription for oral hypoglycemics, insulin, 
glucometer and/or glucometer strips and had a diagno-sis 
of diabetes for at least 12 months, were aged ≥18 and non-
institutionalized. Patients not residing in the canton of 
Vaud, not speaking or understanding French well 
enough, or those presenting with obvious cognitive 
impairment were excluded, as well as women with gesta-
tional diabetes. During this two-phase process, 85 phar-
macies agreed to help recruit patients for the study and 
519 eligible patients consented to the study, and com-
pleted and returned the questionnaire. Further details 
about recruitment and participation may be found in the 
published study about the original survey.18
Measures
Data were self-reported and collected using a paper 
mail-in survey that was given to patients during their visit 
to the pharmacy. It addressed the following themes: dia-
betes illness and care management, lifestyle, health 
status and sociodemographics.
Dependent variables
The main dependent variables of our study were two 
HRQoL measures, one generic and one disease-speciﬁc: 
the SF-12 and the Audit of Diabetes-Dependent Quality of 
Life (ADDQoL), respectively. We considered the mental 
composite score (MCS) and physical composite score 
(PCS) of the SF-12 rating, which each range from 0
(worst) to 100 (best).19 The 19-item ADDQoL instru-
ment,20 21 which is highly tailored to important issues of 
daily life for patients with diabetes, has been used among 
various types of populations, and is considered one of the 
few disease-speciﬁc tools with adequate psychometric 
properties.22 23 The 19-item ADDQoL global score ranges 
continuously from −9 (worst) to 3 (best). Validation ana-
lyses for this project of the present French for Switzerland 
version showed a CFI (goodness-of-ﬁt index) of 0.80, and 
a C r o n b a c h ’s α of at least 0.90 for all items.
Exposure variables PoC: 
individual measures
Our main exposure variables were six individual PoC that 
are routinely used to monitor quality of diabetes care in 
practice and in research studies.12 24 The diabetes-speciﬁc 
patient-reported process measures were: HbA1C check 
(yes, 1×/year; yes>1×/year; no; unknown), retinal eye 
examination by ophthalmologist (yes,<1 year ago; yes, 1–2 
years ago; yes, >2 years ago; never; unknown), annual 
urine microalbuminuria screen (yes; no; unknown), 
annual foot examination by physician (yes; no; unknown), 
annual lipid test (yes; no; unknown) and annual inﬂuenza 
vaccination (yes; no; unknown). Owing to a skip question 
survey method, receipt of HbA1c check was only asked to 
those report-ing knowing what HbA1c was (HbA1c-
aware). However, multiple categories were created for the 
HbA1c PoC variable, to include the patients who did not 
know about HbA1c (HbA1c-unaware). The HbA1c 
variable categor-ies were as follows: (1) HbA1c-aware and 
HbA1c was checked; (2) HbA1c-aware and HbA1c was not 
checked;(3) HbA1c-aware and do not know if HbA1c was 
checked; (4) HbA1c-unaware (not HbA1c-aware or do not 
know if HbA1c-aware). The reference category was 
‘HbA1c-aware and HbA1c was not checked.’
PoC: combined measures
We also used two combined measures for the PoC indi-
cators.25 These combined measures were restricted to 
HbA1c-aware patients with no missing data, since these 
respondents were asked about HbA1c check and had 
answered all of the other PoC questions. This means 
that HbA1c-unaware patients and patients with missing 
and ‘do not know’ answers for any other PoC were not 
included in the following two combined measures:
1. Mean percentage of recommended care: the sum of 
received PoC (number of ‘yes’ responses per 
patient), divided by six possible processes.
2. Percentage of patients receiving all of recommended 
care: percentage of patients receiving six process 
measures (patients with all ‘yes’ responses), with ref-
erence to those not receiving all process measures 
(patients with ‘no’ for any of the six indicators).
Patient Assessment of Chronic Illness Care measure
Our last exposure variable was the Patient Assessment of 
Chronic Illness Care (PACIC) global score (range from
2
1-never to 5-always), which was used as an overall PoC 
measure, assessing to what extent current care is congru-
ent with the Chronic Care Model.26 It does not incorp-
orate the aforementioned PoC variables but, rather, 
bases its metrics on an evidence-based theoretical frame-
work for chronic disease care.
Covariates
We considered other patient and clinical variables given 
their potential confounding with the association between 
PoC receipt and HRQoL.5 2 7 –29 These variables included 
(1) demographics: age, gender, education (primary, sec-
ondary, tertiary), quartiles of monthly income level in 
CHF (≤3499, 3500–5499, 5500–9499, ≥9500), living com-
panion (lives with someone at home, yes/no), (2) medical 
history: alcohol consumption (history of alcohol 
problems, yes/no), smoking (currently smoking, yes/no), 
body mass index (underweight/normal, overweight, 
obese), physical inactivity (no physical activity, yes/no), 
number of medical/psychiatric comorbidities and (3) 
diabetes characteristics and disease severity: diabetes type 
(type 2/undetermined, type 1), treatment (on insulin, 
yes/no), diabetes complications (presence of at least one 
of the following diabetes complications: cardiovascular 
disease, stroke, retinopathy, chronic kidney insufﬁciency, 
regular dialysis or kidney transplant, neuropathy, foot 
ulcer/wound, lower extremity amputation and severe 
hypoglycemia or hyperglycemia,) and duration of dia-
betes illness (10 years or more, yes/no). In order to not 
lose cases in fully adjusted models, missing and ‘do not 
know’ responses (if these two totaled over 10) were incor-
porated into a separate category for each variable.
Statistical analysis
First, we conducted descriptive analyses to describe the 
population, as well as HRQoL scores and PoC received. 
Next, we performed bivariate analyses to examine the 
association between each of the three HRQoL outcomes 
(SF12-MCS, SF12-PCS, ADDQoL) and each single PoC 
indicator. Using the ANOVA test, we assessed 
whether there were any differences in HRQoL 
mean scores between respondents for each PoC 
indicator, comparing report of receipt and no receipt of 
each PoC.
We then performed linear regressions of HRQoL out-
comes and PoC. First, crude linear regression models 
for each of the three outcomes simultaneously included 
the six individual PoC (no covariates). All models were 
then adjusted for demographics, medical history and 
diabetes characteristics variables. Second, we used the 
two PoC combined measures and the PACIC to examine 
the association with the three HRQoL outcomes, in 
crude and adjusted models.
Finally, we performed a sensitivity analysis for the com-
bined PoC measures to include all patient cases. This 
consisted of creating a combined measure to include 
patients with missing data as well as HbA1c-unaware 
patients who were not asked the HbA1c-receipt question 
(because they responded ‘no’ or ‘do not know’ to
awareness about HbA1c). In this sensitivity analysis 
(worst case scenario), the HbA1c-unaware patients were 
assumed as not having an HbA1c screen. Similarly, all 
patients with missing/‘do not know’ responses for each 
of the other indicators were counted as ‘no’ answers, 
thus giving a complete observation set of 519 patients 
for this combined measure sensitivity analysis. The sum 
of received PoC (number of ‘yes’ responses) was com-
puted. We then used this combined measure to examine 
the association with the three HRQoL outcomes, in 
crude and adjusted models.
Checks for linearity and colinearity were performed in 
initial bivariate analyses. Residuals in each linear regres-
sion model were tested for normality and for homosce-
dasticity. We crosschecked all model results using 
transformed versions of the dependent variables, and 
these did not differ from the initial ﬁndings, nor did they 
provide a better residual distribution, which con-ﬁrmed 
results of the original models used. To take into account 
the intragroup correlation of individuals within 
pharmacies, the clustered sandwich estimator was used to 
estimate the variance–covariance matrix (VCE). STATA 
V.12.0 was used for all analyses.
Written informed consent was obtained from all parti-
cipants, and data were kept conﬁdential.
RESULTS
Description of the study population is shown in table 1. 
Among respondents, mean age was 64.5 years and almost 
60% were men. The majority had a high school equiva-
lent education or above (81%) and lived with someone at 
home (73%). While 17% were current smokers, 47%were 
classiﬁed as obese and nearly 30% were physically inactive. 
The average number of comorbidities per patient was 1.8. 
The majority of patients reported having type 2 diabetes 
(67%), 12.7% reported type 1 diabetes; diabetes type 
diagnosis was unknown by 20% of respon-dents. Almost 
50% required insulin treatment and close to half self-
reported at least one diabetes-related compli-cation. The 
highest-reported diabetes complications were eye 
problems (with attention to the retina; 18%), stroke or 
ischemic heart disease (15%) and hypoglycemia or 
hyperglycemia (11%). Finally, 48% of patients had had a 
diabetes diagnosis of greater than 10 years.
Table 2 presents the HRQoL outcomes and PoC results. 
Mean SF-12 MCS and PCS scores were 47.0 (SD 11.2) and 
43.4 (SD 10.6), respectively, and mean ADDQoL score was 
−1.6 (SD 1.6). For individual process variables, about 98% 
of HbA1c-aware patients had had at least one HbA1c 
screen during the past 12 months. During that same time 
period, while screen-ing for lipids was similarly high 
(94.2%), around 60–70% of the patients reported having 
received the other four individual process indicators, with 
the lowest corre-sponding to microalbuminuria screening 
(63.3%). Combined PoC measures show that HbA1c-
aware indivi-duals received about 86% of the six PoC 
indicators
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considered, and about 40% of these patients received all 
six PoC. Results of the combined sensitivity analysis con-
sidering all 519 patients showed that at least 18.9%
patients received six of the six processes-of-care; this is a 
result that tests a ‘worst-case’, where HbA1c-unaware for 
HbA1c, and missing and ‘don’t know’ responses for any 
PoC receipt are considered as a ‘no’ answer.
The comparisons of mean HRQoL scores across cat-
egories of patients having reported (+) or not (−) a spe-
ciﬁc PoC are shown in table 3. Only a few comparisons 
were statistically signiﬁcant. On the one hand, patients 
who received the inﬂuenza vaccine compared to those 
who did not, had lower ADDQoL scores (−1.7 vs −1.3, 
respectively) and lower PCS scores (41.8 and 46.2, 
respectively), and those receiving the retinal examin-ation 
reported worse ADDQoL score (−1.7), compared to those 
who did not receive this examination (−1.2). On the 
other hand, patients with HbA1c checks
reported better ADDQoL than those who did not report 
any HbA1c check during the past 12 months. Of note, 
there were no signiﬁcant differences in HRQoL out-
comes between the HbA1c-aware and the HbA1c-unaware 
groups (data not shown).
Crude and adjusted linear regressions of models 
including all individual PoC (table 4) suggest that while 
there were no associations between the receipt of single 
PoC and SF-12 MCS, receiving a foot examination by a 
physician was negatively associated with the SF-12 PCS 
score (ie, worse HRQoL: β=−1.8) in the fully adjusted 
model. Also, receipt of inﬂuenza vaccine was associated 
with lower ADDQoL in crude and in adjusted models (β=
−0.4).
Regarding combined measures of PoC (table 5), there 
was no association with HRQoL in the adjusted models. 
However, the sensitivity test (‘worst case’) did show that 
each additional PoC received was associated with a 
decrease in ADDQoL score (β=−0.1).
Finally, PACIC was positively associated with HRQoL, 
with an increase in the SF-12 MCS score (β=1.6) for each 
additional point on the PACIC global score (table 5).
DISCUSSION
The results of this study suggest that overall there were no 
consistently signiﬁcant associations between patients’ self-
report of receipt of diabetic PoC and HRQoL. In fact, save 
for the PACIC score showing that care more congruent 
with the Chronic Care Model was positively associated 
with better SF-12 MCS score, and HbA1c being positively 
associated with better ADDQoL global score, there was 
either no association or a trend towards the negative. The 
ﬁndings were similar when we tested process indicators as 
combined measures.
These ﬁndings were somewhat unexpected since we 
hypothesized that receipt of PoC would lead, ultimately, to 
better clinical outcomes, and thus better HRQoL. Indeed, 
PoC have been shown to improve diabetic clin-ical 
markers such as HbA1c levels and cardiometabolic risk 
factors,30 thereby decreasing morbidity and mortal-ity.14 31 
32 Since less morbid patients report a better 
HRQoL,5 3 3 3 4 we expected to see a positive association 
between PoC and HRQoL.
One possible reason for this discordance is that, in fact, 
receipt of PoC does not always translate to an obser-vation 
of improved clinical outcomes for diabetes. In the third 
National Health and Nutrition Examination Survey 
(NHANES III), rates of health services use and diabetic 
complications screening and hyperglycemia, high-blood 
pressure and cholesterol treatment/therapy in patients 
with type 2 diabetes were high; however, despite the rise 
of these indicators, health status and outcomes did not 
reﬂect a signiﬁcant improvement.35 Hypotheses for this 
ﬁnding included patient and healthcare system factors 
that did not allow for appropriately meeting patients’ 
needs. Similarly, in the Translating Research Into Action
Table 1 Characteristics of included patients with diabetes 
(n=519)
64.5 (SD 11.3)
59.7%
Demographics 
Mean age (n=519) 
Male (n=519) 
Education (n=504)
18.9%
56.2%
Primary 
Secondary 
Tertiary 25.0%
Monthly income (CHF; n=486)
21.2%
26.5%
27.8%
17.3%
≤3499 
3500–5499 
5500–9499 
≥9500
‘do not know’ 7.2%
Lives with someone (n=516) 73.2%
17.3%
5.9%
Medical history
Current smoker (n=509)
History of alcohol problems (n=505) 
BMI (n=481)
0.8%
17.1%
35.3%
Underweight 
Normal 
Overweight 
Obese 46.8%
1.8 (SD 1.3)Mean number of comorbidities (n=505) 
Physically inactive (n=494) 29.8%
Diabetes characteristics
Diabetes type 2 or undetermined (n=519) 87.3%
Diabetes requiring insulin (n=516) 48.8%
46.7%Any diabetes complications* (n=505) 
Diabetes duration (n=511, years)
27.6%
24.5%
18.6%
11.9%
1–5 6–
10 11–
15 16–
20 over 
20 17.4%
*At least one diabetes complication: cardiovascular disease,
stroke, retinopathy, chronic kidney insufficiency, dialysis, 
neuropathy, ulcer, amputation and severe hypoglycemia or 
hyperglycemia.
BMI, body mass index.
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(TRIAD) study, though an average of one additional
documented PoC for each patient in a group or plan
was associated with signiﬁcantly lower mean low-density
lipoprotein cholesterol levels, this was not observed 
with HbA1c, systolic blood pressure or high-density-
lipoprotein cholesterol levels.24 Finally, in a review of 24
Table 2 HRQoL scores and processes-of-care among included patients with diabetes (n=519)
HRQoL outcomes (n) Mean (SD)
SF-12 MCS 496 47.0 (11.2)
SF-12 PCS 498 43.4(10.6)
ADDQoL 512 −1.6 (1.6)
Individual process-of-care (at least one check in last 12 months) Percentage that received process
Hemoglobin A1c among ‘aware’ patients 282 98.3
Lipid 513 94.2
Urine microalbumin 512 63.3
Foot examination by physician 510 66.5
Retinal eye examination (in last 24 months) 511 75.7
Flu vaccination 514 63.8
Combined process-of-care measures
Mean percentage of recommended care* 236 85.9
Percentage of patients receiving all care* 236 41.5
PACIC Mean (SD)
Global score 503 2.8 (0.95)
*Complete observations with no missing data (among HbA1c-aware patients only).
ADDQoL, Audit of Diabetes-Dependent Quality of Life; HRQoL, health-related quality of life; PACIC, Patient Assessment of Chronic Illness
Care; SF-12, short form-12
Table 3 HRQoL outcome across individual processes-of-care, for those reporting it as having been performed (+) or not (−)
Health-related quality of life measures
Mean (SD) Mean (SD)
PoC not reported (−) PoC reported (+) p Value*
Lipids
SF-12 MCS 48.4 (9.1) 46.9 (11.3) 0.68
SF-12 PCS 42.2 (11.8) 43.5 (10.5) 0.76
ADDQoL −1.5 (1.4) −1.6 (1.6) 0.77
Urine microalbumin
SF-12 MCS 46.6 (11.4) 47.4 (11.1) 0.54
SF-12 PCS 41.6 (9.8) 44.0 (10.6) 0.12
ADDQoL −1.5 (1.5) −1.6 (1.6) 0.48
Foot examination
SF-12 MCS 46.7 (11.0) 47.2 (11.2) 0.66
SF-12 PCS 44.1 (9.0) 43.1 (11.2) 0.59
ADDQoL −1.5 (1.4) −1.6 (1.6) 0.72
Retinal eye examination
SF-12 MCS 47.8 (10.6) 46.9 (11.3) 0.39
SF-12 PCS 43.8 (11.0) 43.2 (10.5) 0.38
ADDQoL −1.2 (1.5) −1.7 (1.6) 0.01
Hemoglobin A1c†
SF-12 MCS 42.0 (10.1) 46.6 (11.6) 0.64
SF-12 PCS 30.0 (14.9) 43.7 (10.9) 0.18
ADDQoL −2.8 (0.98) −1.8 (1.7) 0.01
Flu vaccination p value‡
SF-12 MCS 47.4 (10.9) 46.8 (11.3) 0.58
SF-12 PCS 46.2 (9.9) 41.8 (10.6) 0.000
ADDQoL −1.3 (1.3) −1.7 (1.7) 0.001
*F-test for ANOVA.
†Results displayed for HbA1c-aware patients only.
‡Two sample t tests with equal variances.
ADDQoL, Audit of Diabetes-Dependent Quality of Life; ANOVA, analysis of variance; HbA1c, glycated hemoglobin; MCS, mental composite
score; PCS, physical composite score; PoC, processes-of-care; SF-12, short form-12.
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studies looking at the association of diabetes quality-of-
care with surrogate and clinical outcomes, high-quality 
studies speciﬁcally examining process indi-cators (number 
of tests or visits) showed mostly incon-sistent or negative 
associations.36 Perhaps we could not ﬁnd an improvement 
in HRQoL because the patients observed in this study did 
not clinically beneﬁt from the PoC received at the time of 
the survey.
Another postulation is the confounding of severity of
disease with more intense PoC, and thus low HRQoL.
We did try to control for this by adjusting for diabetes-
speciﬁc characteristics and comorbidity; it is, however,
still possible that we did not sufﬁciently account for all
aspects of illness severity that are linked to lower
HRQoL. In addition, increased medical treatment (such
as increased doctor visits and medical testing) may lead
to patient worry and inconvenience, and decreased
patient HRQoL. Although we did not ﬁnd studies docu-
menting the effects of PoC on patient stress levels, the
intensiﬁcation of some medical treatment (such as the
Table 4 Linear regression models of HRQoL and individual processes-of-care in crude and adjusted models
HRQoL outcomes
MCS PCS ADDQoL
β= β= β=
Process indicators† Crude Adjusted Crude Adjusted Crude Adjusted
Lipids −2.6 −3.4 −0.05 2.1 −0.005 −0.03
Urine microalbumin 1.2 0.95 1.8 0.5 −0.1 0.05
Foot examination by physician 1.1 0.9 −1.5 −1.8* −0.1* 0.2
Retinal eye examination (in past 24 months) −0.7 −0.2 −0.5 1.1 −0.3 −0.2
Flu vaccination −0.3 −0.8 −4.2α −1.4 −0.4** −0.4**
Hemoglobin A1c‡
HbA1c-aware and HbA1c was checked 4.8 1.4 14.9* 3.5 1.2 0.3
HbA1c-aware and do not know if HbA1c was checked 1.5 −2.7 19.1* 4.6 2.2 0.8
HbA1c-unaware (not aware or do not know if aware of
HbA1c)
6.2 0.5 13.7* 3.8 1.6 0.4
Adjusted. R2 for full model 0.11 0.39 0.21
Crude model=all process indicator in one model, no other covariates.
Adjusted model=all process indicators+14 covariates (demographics, medical history and diabetes characteristics).
Covariates:
Demographics: Age, Male, Education levels, Income levels, Living companion.
Medical hx: hx of alcohol problems, smoker, BMI category, comorbidities, physical activity.
Diabetes: type 2 or undetermined, on insulin, DM complications, DM over 10 years.
*p≤0.05; **p≤0.01; αp≤0.001.
†Reference: no care received for individual process-of-care.
‡Reference: HbA1c-aware and did not receive HbA1c screen/check.
HbA1c, glycated hemoglobin; HRQoL, health-related quality of life.
Table 5 Crude and adjusted linear regression models of (1) HRQoL and combined processes-of-care, (2) HRQoL and 
PACIC, in crude and adjusted models
HRQoL outcomes
MCS PCS ADDQoL
Crude Adjusted Crude Adjusted Crude Adjusted
Mean percentage of recommended care† 5.9 4.5 −4.0 −2.1 −1.4 −0.8
Adjusted R2 for full model 0.18 0.35 0.19
Receiving all recommended care† 0.3 0.1 −0.7 0.1 −0.4 −0.2
Adjusted R2 for full model 0.17 0.35 0.19
Sensitivity analysis‡ −0.1 0.2 −0.4 −0.3 −0.2 −0.1*
Adjusted R2 for full model 0.12 0.39 0.21
PACIC score 0.96 1.6* 0.5 −0.6 −0.1 −0.1
Adjusted R2 for full model 0.13 0.39 0.20
Crude model=combined process-of-care measure, no other covariates.
Adjusted model=combined measure +14 covariates (demographics, medical history and diabetes characteristics).
Covariates:
Demographics: Age, Male, Education levels, Income levels, Living companion.
Medical hx: hx of alcohol problems, smoker, BMI category, co-morbidities, physical activity.
Diabetes: type 2 or undetermined, on insulin, DM complications, DM over 10 years.
*p≤0.05.
†Complete case: yes=1; no=0; all other answers=missing.
‡Worst case: yes=1; all other answers (HbA1c-unaware for HbA1c; no, missing, do not know for all other PoC)=0.
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transition from oral hypoglycemics to insulin) has been 
linked to higher stress and worry and lower HRQoL 
among patients with type 2 diabetes, though this rela-
tionship was inconsistent.5
One more readily possible explanation is that the lack 
of association represents an effect lag time between time 
of process received and impact on HRQoL; cross-sectional 
data are not ideal to detect such an effect. Other studies 
have also described the need to measure quality of care 
and patient outcomes, over time, in order to most accur-
ately reﬂect these relationships.10 37 38 As such, the rela-
tionship between PoC and HRQoL might be further 
elucidated through a longitudinal examination, and thus 
should be a priority for future diabetic cohort studies.
Owing to this possible time-effect issue, one postulation 
was that receipt of PoC could be associated with a more 
immediate surrogate of patients’ experiences, such as 
patient satisfaction. For example, the TRIAD study showed 
that the number of care processes documented was asso-
ciated with patient satisfaction measures and self-rated 
quality of diabetes care.24 In post hoc analyses, we indeed 
observed a similar positive trend between PoC and ‘very 
good/excellent’ patient ratings on care satisfaction (vs 
‘bad/medium/good’) a n d  f e e l i n g  ‘very well/well 
informed’ (vs ‘very bad/bad/medium’), across individual 
and com-bined PoC measures, as well as the PACIC global 
score.
This study is unique in that we attempted to examine
the speciﬁc association between PoC and HRQoL
among a population-based sample of patients with dia-
betes, a topic that, to the best of our knowledge, has not
yet been studied. We employed generic as well as
diabetes-speciﬁc HRQoL outcomes, and a range of
measurement for PoC (individual, combined, PACIC).
However, our results need to be interpreted in light of
the following limitations. First, since we used a cross-
sectional design, we cannot make conclusions about
causal associations even though exposure to PoC was
measured, retrospectively, for the previous year(s).
Second, our sample size, calculated for getting appropri-
ate precision around our primary outcomes, may have
been too small to detect signiﬁcant associations in sec-
ondary analysis. Another sample issue is that our com-
bined analyses were limited to 236 of the 519 patients
because of the skip question method for the question of
HbA1c check receipt. In order to not eliminate the
HbA1c-unaware patients from the combined measures,
we constructed a third measure that was tested in the
analysis where patients who responded ‘no’ or ‘do not
know’ to knowing about HbA1c were assumed to not
have received an HbA1c screen. A further point to con-
sider is the relation between PoC measures and quality
of life for patients with a speciﬁc complication (ie, how
is quality of life affected in patients with retinopathy who
receive an annual retinal examination compared to
patients with diabetes who do not have retinopathy and
receive annual retinal examinations?). Unfortunately,
the sample size for many of these speciﬁc complication
groups is much too small for further reliable analysis.
Third, the generalizability of these results is limited 
because the studied population may not be representa-
tive of the true population of patients with diabetes. We 
are nevertheless conﬁdent that our population-based 
sampling method, which utilized community pharmacies 
in the recruitment process, ensured the representative-
ness of patients with diabetes in the community (not just 
in clinic and hospital settings). Furthermore, character-
istics of our patients with diabetes were similar to those 
reported from a population-based cohort study con-
ducted in the same area.39 Last, we used self-reported data 
that may be prone to recall bias; however, supple-mentary 
analyses for this project demonstrated good cor-relation 
between patient-reported data and physician records for 
simple PoC, when data was supplied by the treating 
physician for a fraction of the cohort.40
In conclusion, further research should focus on the 
effects of PoC on patient-reported outcomes, particularly 
from a patient-centered perspective. Our study probes 
healthcare stakeholders to look beyond the presence of 
PoC procedures as the sole measurement of ‘good care.’ 
Additional studies, speciﬁcally with longitudinal data, are 
needed to examine the way in which PoC will translate 
into better health for patients with diabetes and, ultim-
ately, a better quality of life. This includes looking into the 
way these PoC are conducted, how often they are 
delivered and what clinical cut-offs are being used. 
Although our study is a ‘ﬁrst look,’ and more investiga-
tion is needed, we demonstrated that a list of achieved 
PoC is not a simple surrogate for gauging improvement 
on patient quality of life. Health systems and providers 
must ensure that diabetic care resources are allocated 
appropriately and organized effectively, so that patients 
with diabetes are able to thrive in life despite their illness.
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